We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people. Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine. The Lancet, a respected medical journal in the UK, published the results on Friday saying it is “safe” and “induces rapid immune response.”
The Lancet published the phase-1 trial results of a possible COVID-19 vaccine from China. It seems to be safe and effective. But it has to go through more trials before being put on the market.
Comments are closed.